Previous research has shown that gene mutations in certain patients with gastric cancer, colorectal cancer, and pancreatic cancer can cause a decrease or absence of laminin β4 (LAMB4) expression [52,53]. The gene discussed is LAMB4; the disease is pancreatic neoplasm.